ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations

May 23, 2003

Symposium Addresses FCC issues

February 21, 1986

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis

May 26, 2006

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976